Bibliographie

1.
American Psychological Association. Answers to your questions about transgender people, gender identity, and gender expression. https://www.apa.org/topics/lgbtq/transgender; 2014.
2.
Ainsworth C. Sex redefined. Nature. 2015 Feb;518(7539):288–91.
3.
Van Lisdonk J. Living with intersex/DSD : An exploratory study of the social situation of persons with intersex/DSD. Netherlands Institute for Social Research. La Haye: Netherlands Insitute for Social Research; 2014.
4.
Flores AR, Herman JL, Gates GJ, Brown TNT. How many Adults identify as Transgender in the United States? Los Angeles, CA: The Williams Institue; 2016 p. 13.
5.
Goodman M, Adams N, Corneil T, Kreukels B, Motmans J, Coleman E. Size and Distribution of Transgender and Gender Nonconforming Populations. Endocrinology and Metabolism Clinics of North America. 2019 Jun;48(2):303–21.
6.
Commission de profils des m’edecins g’en’eralistes. Campagne d’information 2015 de la Commission de profils des médecins généralistes : Rapport d’activité personnel 2013. INAMI - Direction Recherche, Développement et promotion de la Qualité; 2015.
7.
Ordre des M’edecins. Genre et soins de santé. Ordomedic. https://ordomedic.be/fr/avis/maladies/transsexualite/gender-en-gezondheidszorg; 2021.
8.
McNeil J, Bailey L, Ellis S, Morton J, Regan M. Trans Mental Health and Emotional Wellbeing Study. Edinburgh: Scottish Transgender Alliance; 2012. Report No.: September.
9.
Witcomb GL, Bouman WP, Claes L, Brewin N, Crawford JR, Arcelus J. Levels of depression in transgender people and its predictors: Results of a large matched control study with transgender people accessing clinical services. Journal of Affective Disorders. 2018 Aug;235:308–15.
10.
Marshall E, Claes L, Bouman WP, Witcomb GL, Arcelus J. Non-suicidal self-injury and suicidality in trans people: A systematic review of the literature. International Review of Psychiatry. 2016 Jan;28(1):58–69.
11.
Motmans J, Wyverkens E, Defreyne J. Être une personne transgenre en Belgique : 10 ans plus tard. Pasteel M, editor. Bruxelles, Belgique: Institut pour l’égalité des femmes et des hommes; 2017.
12.
Wirtz AL, Poteat TC, Malik M, Glass N. Gender-Based Violence Against Transgender People in the United States: A Call for Research and Programming. Trauma, Violence, & Abuse. 2020 Apr;21(2):227–41.
13.
Peitzmeier SM, Malik M, Kattari SK, Marrow E, Stephenson R, Ag’enor M, et al. Intimate Partner Violence in Transgender Populations: Systematic Review and Meta-analysis of Prevalence and Correlates. American Journal of Public Health. 2020 Sep;110(9):e1–4.
14.
James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality; 2016.
15.
Pitasi MA, Kerani RP, Kohn R, Murphy RD, Pathela P, Schumacher CM, et al. Chlamydia, Gonorrhea, and Human Immunodeficiency Virus Infection Among Transgender Women and Transgender Men Attending Clinics that Provide Sexually Transmitted Disease Services in Six US Cities. Sexually Transmitted Diseases. 2019 Feb;46(2):112–7.
16.
Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006. American Journal of Public Health. 2019 Jan;109.
17.
Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychological Bulletin. 2003;129(5):674–97.
18.
Testa RJ, Habarth J, Peta J, Balsam K, Bockting W. Development of the Gender Minority Stress and Resilience Measure. Psychology of Sexual Orientation and Gender Diversity. 2015 Mar;2(1):65–77.
19.
Pellicane MJ, Ciesla JA. Associations between minority stress, depression, and suicidal ideation and attempts in transgender and gender diverse (TGD) individuals: Systematic review and meta-analysis. Clinical Psychology Review. 2022 Feb;91:102113.
20.
Pampati S, Andrzejewski J, Steiner RJ, Rasberry CN, Adkins SH, Lesesne CA, et al. “We Deserve Care and we Deserve Competent Care”: Qualitative Perspectives on Health Care from Transgender Youth in the Southeast United States. Journal of Pediatric Nursing. 2021 Jan;56:54–9.
21.
Teti M, Kerr S, Bauerband LA, Koegler E, Graves R. A Qualitative Scoping Review of Transgender and Gender Non-conforming People’s Physical Healthcare Experiences and Needs. Frontiers in Public Health. 2021;9.
22.
Hostetter CR, Call J, Gerke DR, Holloway BT, Walls NE, Greenfield JC. “We Are Doing the Absolute Most That We Can, and No One Is Listening”: Barriers and Facilitators to Health Literacy within Transgender and Nonbinary Communities. International Journal of Environmental Research and Public Health. 2022;19(3).
23.
Green AE, DeChants JP, Price MN, Davis CK. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth. Journal of Adolescent Health. 2021 Dec;S1054139X21005681.
24.
Genres Pluriels. Atteindre son point de confort ? https://www.genrespluriels.be/Atteindre-son-point-de-confort; 2018.
25.
Clark BA, Virani A. This Wasn’t a Split-Second Decision”: An Empirical Ethical Analysis of Transgender Youth Capacity, Rights, and Authority to Consent to Hormone Therapy. Journal of Bioethical Inquiry. 2021 Jan;
26.
Terricabras J-M. Rapport sur la situation des droits fondamentaux dans l’Union européenne en 2017. Parlement Européen; 2018 p. 26. Report No.: 2018/2103(INI).
27.
Les Principes de Jogjakarta : Principes sur l’application de la législation internationale des droits humains en matière d’orientation sexuelle et d’identité de genre. 2007.
28.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2017 Nov;102(11):3869–903.
29.
Randolph JF. Gender-Affirming Hormone Therapy for Transgender Females: Clinical Obstetrics and Gynecology. 2018 Dec;61(4):705–21.
30.
T’Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V. Endocrinology of Transgender Medicine. Endocrine Reviews. 2019 Feb;40(1):97–117.
31.
Scheres LJJ, Selier NLD, Nota NM, van Diemen JJK, Cannegieter SC, den Heijer M. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen. Journal of Thrombosis and Haemostasis. 2021;19(4):1029–37.
32.
Haupt C, Henke M, Kutschmar A, Hauser B, Baldinger S, Saenz SR, et al. Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. Cochrane Database of Systematic Reviews. 2020;2020(11).
33.
Angus LM, Nolan BJ, Zajac JD, Cheung AS. A systematic review of antiandrogens and feminization in transgender women. Clinical Endocrinology. 2021 May;94(5):743–52.
34.
Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, et al. Health considerations for transgender women and remaining unknowns: A narrative review. Therapeutic Advances in Endocrinology and Metabolism. 2019 Jan;10:204201881987116.
35.
Iwamoto SJ, T’Sjoen G, Safer JD, Davidge-Pitts CJ, Wierman ME, Glodowski MB, et al. Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy for the Benefits of Progesterone in Ciswomen”. The Journal of Clinical Endocrinology & Metabolism. 2019 Aug;104(8):3127–8.
36.
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn’t. BMJ : British Medical Journal. 1996 Jan;312(7023):71–2.
37.
de Blok CJM, Wiepjes CM, Nota NM, van Engelen K, Adank MA, Dreijerink KMA, et al. Breast cancer risk in transgender people receiving hormone treatment: Nationwide cohort study in the Netherlands. BMJ. 2019 May;l1652.
38.
Kotamarti VS, Greige N, Heiman AJ, Patel A, Ricci JA. Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine. 2021 Jul;18(7):1280–91.
39.
Connelly PJ, Marie Freel E, Perry C, Ewan J, Touyz RM, Currie G, et al. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults. Hypertension. 2019 Dec;74(6):1266–74.
40.
Moravek MB. Gender-Affirming Hormone Therapy for Transgender Men. Clinical obstetrics and gynecology. 2018;61(4):687–704.
41.
Yaish I, Tordjman K, Amir H, Malinger G, Salemnick Y, Shefer G, et al. Functional ovarian reserve in transgender men receiving testosterone therapy: Evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment. Human Reproduction. 2021 Oct;36(10):2753–60.
42.
Taub RL, Ellis SA, Neal-Perry G, Magaret AS, Prager SW, Micks EA. The effect of testosterone on ovulatory function in transmasculine individuals. American Journal of Obstetrics and Gynecology. 2020 Aug;223(2):229.e1–8.
43.
Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. American Journal of Obstetrics and Gynecology. 2020 Feb;222(2):134–43.
44.
Carswell JM, Roberts SA. Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents. Transgender Health. 2017 Dec;2(1):195–201.
45.
Irwig M. Testosterone Therapy for Transgender Men. The lancet Diabetes & endocrinology. 2017;5(4):301–11.
46.
de Blok CJM, Dreijerink KMA, den Heijer M. Cancer Risk in Transgender People. Endocrinology and Metabolism Clinics of North America. 2019 Jun;48(2):441–52.
47.
Pluye P. L’intégration en méthodes mixtes. Cadre conceptuel pour l’intégration des phases, résultats et données qualitatifs et quantitatifs. In: Ridde V, Dagenais C, editors. Évaluation des interventions de santé mondiale : Méthodes avancées. Québec et Marseille: Éditions science et bien commun et IRD Éditions; 2019. p. 187–212.
48.
Ghesquiere F. Catalogue des indicateurs statistiques - WALSTAT. https://walstat.iweps.be/walstat-catalogue.php?niveau_agre=A&indicateur_id=833800&ordre=0&periode=2019&niveau_agre=P&sel_niveau_catalogue=T; 2021.
49.
Wang Y, Ma Z, Wilson A, Hu Z, Ying X, Han M, et al. Psychopathological symptom network structure in transgender and gender queer youth reporting parental psychological abuse: A network analysis. BMC Medicine. 2021 Sep;19(1):215.
50.
SoRelle JA, Jiao R, Gao E, Veazey J, Frame I, Quinn AM, et al. Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clinical Chemistry. 2019 Jan;65(1):170–9.
51.
Meulders Q. MDRDs - CKD-EPI - Cockcroft | SFNDT. https://www.sfndt.org/professionnels/calculateurs/mdrds-ckd-epi-cockcroft; 2022.
52.
Greene DN, Schmidt RL, Winston-McPherson G, Rongitsch J, Imborek KL, Dickerson JA, et al. Reproductive Endocrinology Reference Intervals for Transgender Men on Stable Hormone Therapy. The Journal of Applied Laboratory Medicine. 2021 Jan;6(1):41–50.
53.
Hashemi L, Zhang Q, Getahun D, Jasuja GK, McCracken C, Pisegna J, et al. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy. Journal of Sexual Medicine. 2021;18(9):1662–75.
54.
Velho I, Fighera TM, Ziegelmann PK, Spritzer PM. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: A systematic review. Andrology. 2017;5(5):881–8.
55.
Hall J. Neuroendocrine Control of the Menstrual Cycle. In: Strauss III J, Barbieri R, editors. Yen & Jaffe’s Reproductive Endocrinology : Physiology, pathophysiology and clinical management. Eigth Edition. Philadelphia: Elsevier; 2019. p. 213–36.
56.
Liu P, Veldhuis J. Hypothalamo-Pituitary Unit, Testis, and Male Accessory Organs. In: Strauss III J, Barbieri R, editors. Yen & Jaffe’s Reproductive Endocrinology : Physiology, pathophysiology and clinical management. Eigth Edition. Philadelphia: Elsevier; 2019. p. 213–36.
57.
Service Public F’ed’eral de Justice. Loi du 10/05/2007 relative a la transsexualite. https://etaamb.openjustice.be/fr/loi-du-10-mai-2007_n2007009570.html; Moniteur Belge; 2007.
58.
Koehler A, Strauss B, Briken P, Szuecs D, Nieder TO. Centralized and Decentralized Delivery of Transgender Health Care Services: A Systematic Review and a Global Expert Survey in 39 Countries. Frontiers in Endocrinology. 2021;12.
59.
Ker A, Fraser G, Fleming T, Stephenson C, da Silva Freitas A, Carroll R, et al. “A little bubble of utopia”: Constructions of a primary care-based pilot clinic providing gender affirming hormone therapy. Health Sociology Review. 2021 Jan;30(1):25–40.
60.
Irwig MS. Transgender Care by Endocrinologists in the United States. Endocrine Practice. 2016 Jul;22(7):832–6.
61.
Lee JL, Huffman M, Rattray NA, Carnahan JL, Fortenberry JD, Fogel JM, et al. “I Don’t Want to Spend the Rest of my Life Only Going to a Gender Wellness Clinic”: Healthcare Experiences of Patients of a Comprehensive Transgender Clinic. Journal of General Internal Medicine. 2022;